Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)

March 30, 2026 6:15 AM
BTIG analyst Mark Massaro reiterated a Buy rating and $2.50 price target on Lucid Diagnostics Inc (NASDAQ: LUCD).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments